BRAF gene mutation has been identified in about 6% of human cancers [27], including melanomas (40–50%) [27–29], thyroid cancers (10–70%) [27, 30], colorectal cancers (~10%) [27, 31, 32], and non-small cell lung cancer (3–5%) [27, 33]. The gene discussed is BRAF; the disease is cancer.